{"CAT": {"Ticker": "CAT", "Company": "Caterpillar", "Sector": "Industrials", "Updated": "2022-10-28", "Rating": [{"Date": "2022-10-28", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$196 to $221"}, {"Date": "2022-08-03", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$195"}], "Score": -1.5, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Bernstein", "Deutsche Bank"], "Price_Target": 208.0}, "EW": {"Ticker": "EW", "Company": "Edwards Lifesciences", "Sector": "Health Care", "Updated": "2022-10-28", "Rating": [{"Date": "2022-10-28", "Rating": "Downgrade", "Organization": "Oppenheimer", "Rating_Change": "Outperform to Perform", "Target_Change": ""}, {"Date": "2022-10-26", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$100"}, {"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$96"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$110"}], "Score": 1.25, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Oppenheimer", "Mizuho", "Jefferies", "Barclays"], "Price_Target": 102.0}, "ESS": {"Ticker": "ESS", "Company": "Essex Property Trust", "Sector": "Real Estate", "Updated": "2022-10-28", "Rating": [{"Date": "2022-10-28", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$297 to $250"}, {"Date": "2022-10-19", "Rating": "Resumed", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$280 to $237"}, {"Date": "2022-09-19", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$295"}, {"Date": "2022-09-19", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$273 to $264"}], "Score": -0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Citigroup", "Mizuho", "Jefferies", "Piper Sandler"], "Price_Target": 261.5}, "GILD": {"Ticker": "GILD", "Company": "Gilead Sciences", "Sector": "Health Care", "Updated": "2022-10-28", "Rating": [{"Date": "2022-10-28", "Rating": "Upgrade", "Organization": "Truist", "Rating_Change": "Hold to Buy", "Target_Change": "$76 to $91"}, {"Date": "2022-10-28", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$79 to $96"}, {"Date": "2022-10-04", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$72 to $80"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["JP Morgan", "Truist", "Piper Sandler"], "Price_Target": 89.0}, "GL": {"Ticker": "GL", "Company": "Globe Life", "Sector": "Financials", "Updated": "2022-10-28", "Rating": [{"Date": "2022-10-28", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$115 to $114"}, {"Date": "2022-09-22", "Rating": "Initiated", "Organization": "Raymond James", "Rating_Change": "Strong Buy", "Target_Change": "$138"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Raymond James", "Evercore ISI"], "Price_Target": 126.0}, "INTC": {"Ticker": "INTC", "Company": "Intel", "Sector": "Information Technology", "Updated": "2022-10-28", "Rating": [{"Date": "2022-10-28", "Rating": "Upgrade", "Organization": "Summit Insights", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-10-28", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$30"}, {"Date": "2022-10-24", "Rating": "Initiated", "Organization": "HSBC Securities", "Rating_Change": "Reduce", "Target_Change": "$23"}, {"Date": "2022-10-11", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$40 to $32"}, {"Date": "2022-09-08", "Rating": "Initiated", "Organization": "Stifel", "Rating_Change": "Hold", "Target_Change": "$32"}, {"Date": "2022-08-02", "Rating": "Downgrade", "Organization": "DZ Bank", "Rating_Change": "Hold to Sell", "Target_Change": "$30"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Summit Insights", "DZ Bank", "Needham", "Barclays", "HSBC Securities", "Stifel"], "Price_Target": 29.4}, "LHX": {"Ticker": "LHX", "Company": "L3Harris Technologies", "Sector": "Industrials", "Updated": "2022-10-28", "Rating": [{"Date": "2022-10-28", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$267"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}, {"Date": "2022-09-28", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$238"}, {"Date": "2022-08-30", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$285"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Raymond James", "RBC Capital Mkts", "Wolfe Research", "Credit Suisse", "Wells Fargo"], "Price_Target": 263.33}, "RMD": {"Ticker": "RMD", "Company": "ResMed", "Sector": "Health Care", "Updated": "2022-10-28", "Rating": [{"Date": "2022-10-28", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-10-20", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$245 to $260"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2022-09-08", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2022-08-15", "Rating": "Downgrade", "Organization": "CLSA", "Rating_Change": "Buy to Outperform", "Target_Change": ""}, {"Date": "2022-08-12", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$246 to $252"}, {"Date": "2022-08-12", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": ""}, {"Date": "2022-08-12", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": ""}], "Score": -0.12, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 8, "Period": "180 days", "Letter_Rating": "C", "Analists": ["RBC Capital Mkts", "JP Morgan", "Citigroup", "BofA Securities", "Jefferies", "CLSA"], "Price_Target": 256.0}, "SWK": {"Ticker": "SWK", "Company": "Stanley Black & Decker", "Sector": "Industrials", "Updated": "2022-10-28", "Rating": [{"Date": "2022-10-28", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$85 to $80"}, {"Date": "2022-10-14", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$125 to $79"}, {"Date": "2022-10-12", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$110 to $82"}, {"Date": "2022-08-17", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$126 to $111"}, {"Date": "2022-08-01", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$105"}], "Score": -1.6, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Credit Suisse", "Deutsche Bank", "Wells Fargo", "Robert W. Baird", "Morgan Stanley"], "Price_Target": 91.4}, "WST": {"Ticker": "WST", "Company": "West Pharmaceutical Services", "Sector": "Health Care", "Updated": "2022-10-28", "Rating": [{"Date": "2022-10-28", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$385 to $250"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["BofA Securities"], "Price_Target": 250.0}, "WU": {"Ticker": "WU", "Company": "Western Union", "Sector": "Information Technology", "Updated": "2022-10-28", "Rating": [{"Date": "2022-10-28", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Neutral to Sell", "Target_Change": "$12"}, {"Date": "2022-10-17", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": ""}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Citigroup", "UBS"], "Price_Target": 12.0}}